SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-011717
Filing Date
2017-05-03
Accepted
2017-05-03 19:38:44
Documents
1
Period of Report
2017-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15285
  Complete submission text file 0000899243-17-011717.txt   18599
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address HYBRIDON INC 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address
ZEIN YOUSSEF EL (Reporting) CIK: 0001193366 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 17811300

Mailing Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313
Business Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313 0119611363362
Pillar Pharmaceuticals I LP (Reporting) CIK: 0001534425 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 17811302

Mailing Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER, BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313
Business Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER, BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313 0119611363362
Pillar Invest Corp (Reporting) CIK: 0001534428 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 17811303

Mailing Address STARCO CENTER BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT 2020-3313 M8 2020-3313
Business Address STARCO CENTER BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT 2020-3313 M8 2020-3313 9611363362
Pillar Pharmaceuticals II, L.P. (Reporting) CIK: 0001562069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 17811301